Assenagon Asset Management S.A. Halozyme Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 3,880 shares of HALO stock, worth $198,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,880

Previous 43,950 91.17%

Holding current value

$198,617

Previous $2.3 Million 90.4%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$51.3 - $64.42 $2.06 Million - $2.58 Million	-40,070 Reduced 91.17%	3,880 $221,000
Q2 2024 Jul 18, 2024	SELL	$37.81 - $52.4 $336,130 - $465,836	-8,890 Reduced 16.82%	43,950 $2.3 Million
Q1 2024 Apr 24, 2024	SELL	$33.68 - $41.95 $2.44 Million - $3.04 Million	-72,367 Reduced 57.8%	52,840 $2.15 Million
Q4 2023 Jan 17, 2024	BUY	$33.32 - $42.1 $1.8 Million - $2.28 Million	54,063 Added 75.99%	125,207 $4.63 Million
Q3 2023 Nov 06, 2023	SELL	$36.46 - $44.03 $9.87 Million - $11.9 Million	-270,620 Reduced 79.18%	71,144 $2.72 Million
Q2 2023 Jul 25, 2023	SELL	$30.28 - $38.74 $3.37 Million - $4.31 Million	-111,220 Reduced 24.55%	341,764 $12.3 Million
Q1 2023 Apr 18, 2023	BUY	$32.86 - $55.7 $9.67 Million - $16.4 Million	294,313 Added 185.49%	452,984 $17.3 Million
Q4 2022 Jan 12, 2023	BUY	$40.06 - $59.44 $5.8 Million - $8.6 Million	144,735 Added 1038.57%	158,671 $9.03 Million
Q2 2022 Jul 27, 2022	SELL	$37.35 - $48.3 $405,508 - $524,393	-10,857 Reduced 43.79%	13,936 $613,000
Q1 2022 Apr 25, 2022	SELL	$31.97 - $41.06 $3,101 - $3,982	-97 Reduced 0.39%	24,793 $989,000
Q4 2021 Feb 01, 2022	BUY	$31.82 - $40.75 $66,885 - $85,656	2,102 Added 9.22%	24,890 $1 Million
Q3 2021 Oct 19, 2021	BUY	$38.47 - $46.42 $876,654 - $1.06 Million	22,788 New	22,788 $927,000
Q1 2021 Apr 26, 2021	SELL	$39.51 - $51.45 $9.29 Million - $12.1 Million	-235,206 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$25.81 - $43.62 $6.07 Million - $10.3 Million	235,206 New	235,206 $10 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.13B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Halozyme Therapeutics, Inc. Transaction History